Making The Lives Of Patients And Research Sites Easier: Choice Is The Next Chapter For Clinical Trials
By Bree Burks, Veeva

Despite the increasing use of hybrid clinical trials, most participants still don’t have a say in how or where their study visits take place. Research sites, meanwhile, are left juggling dozens of sponsor-mandated applications, slowing trial startup and frustrating staff. The industry is starting to realize that empowering both groups with choice—through standardized, flexible technology—can drive better outcomes across the board. From simplifying patient consent to streamlining site workflows, sponsors that embrace collaboration are seeing gains in quality, efficiency, and enrollment.
Explore how giving sites and patients a voice leads to better trials—read the full article.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.